One in a million.

What would you do with 1 million Gray? Wait, do you mean all at once? It sounds like a question for the space force, but it's actually a new feature at the annual ASTRO radiation oncology meeting aimed to answer what research question radiation oncologists think is the most pressing for the next 3-5 years. The latest report indicates it boils down to the integration of radiation therapy with immunotherapy, genomic medicine, and the expanding population of patients with oligometastatic disease (check). | Dominello, Int J Radiat Oncol Biol Phys 2018